Table 4.
Patients' clinical characteristics by disease category, cumulatively for the entire follow up period
Characteristics of patients
(P-value1) |
ACA+/SS (n = 20) [%] |
SSc/(+) sicca (n = 31) [%] |
SSc/(-) sicca (n = 20) [%] |
ACA-/SS (n = 61) [%] |
---|---|---|---|---|
Positive MSGB (0.039) | 18 [94.7] | 12 [75.0] | - | 54 [94.7] |
P-values2 | 0.156 | 1.000 | ||
Abnormal Rose Bengal (0.364) | 8 [72.7] | 9 [56.3] | 0 [0.0] | 22 [71.0] |
P-values2 | 0.448 | 0.333 | 1.000 | |
Abnormal Schirmer test (0.176) | 9 [64.3] | 14 [87.5] | 0 [0.0] | 35.5 [71.4] |
P-values2 | 0.204 | 0.400 | 0.743 | |
Abnormal BUT (0.428) | 7 [77.8] | 9 [75.0] | 0 [0.0] | 18 [69.2] |
P-values2 | 1.000 | 0.300 | 1.000 | |
Lymphadenopathy (0,249) | 3 [15.0] | 8 [25.8] | 1 [5.0] | 9 [14.8] |
P-values2 | 0.493 | 0.605 | 1.000 | |
Raynaud (<0.0001) | 15 [75.0] | 31 [100.0] | 20 [100.0] | 11 [18.0] |
P-values2 | 0.007 | 0.047 | <0.0001 | |
SGE (0.006) | 3 [15.0] | 4 [12.9] | 0 [0.0] | 20 [32.8] |
P-values2 | 1.000 | 0.231 | 0.160 | |
Purpura (0,052) | 2 [10.0] | 1 [3.2] | 0 [0.0] | 11 [18.0] |
P-values2 | 0.553 | 0.487 | 0.502 | |
Xerostomia (<0.0001) | 19 [95.0] | 25 [80.6] | 0 [0.0] | 53 [86.9] |
P-values2 | 0.223 | <0.0001 | 0.440 | |
Dry eyes (<0.0001) | 17 [85.0] | 29 [93.5] | 0 [0.0] | 60 [98.4] |
P-values2 | 0.369 | <0.0001 | 0.045 | |
Telangiectasias (<0.0001) | 2 [10.0] | 28 [90.3] | 14 [70.0] | 2 [3.3] |
P-values2 | <0.0001 | <0.0001 | 0.254 | |
Puffy fingers (<0.0001) | 7 [35.0] | 26 [83.9] | 14 [70.0] | 10 [16.4] |
P-values2 | 0.001 | 0.056 | 0.112 | |
Sclerodactyly (<0.0001) | 0 [0.0] | 31 [100.0] | 19 [95.0] | 0 [0.0] |
P-values2 | <0.0001 | <0.0001 | - | |
Calcinosis (0. 001) | 0 [0.0] | 6 [19.4] | 4 [20.0] | 0 [0.0] |
P-values2 | 0.070 | 0.106 | - | |
Ulcers (0.249) | 2 [10.0] | 17 [54.8] | 11 [55.0] | 0 [0.0] |
P-values2 | 0.001 | 0.006 | 0.059 | |
Dysphagia (<0.0001) | 7 [35.0] | 18 [58.1] | 5 [25.0] | 4 [6.6] |
P-values2 | 0.153 | 0.731 | 0.004 | |
GER (<0.0001) | 3 [15.0] | 20 [64.5] | 10 [50.0] | 6 [9.8] |
P-values2 | 0.001 | 0.041 | 0.682 | |
Arthritits (0.372) | 8 [35.0] | 10 [32.3] | 4 [20.0] | 14 [23.0] |
P-values2 | 0.765 | 0.301 | 0.156 | |
Dyspnoea (<0.0001) | 7 [40.0] | 20 [64.5] | 5 [25.0] | 9 [14.8] |
P-values2 | 0.049 | 0.731 | 0.060 | |
PAH (0.004) | 2 [10.0] | 8 [25.8] | 2 [10.0] | 1 [1.6] |
P-values2 | 0.280 | 1.000 | 0.149 | |
Ground glass HRCT (0.606) | 0 [0.0] | 4 [21.1] | 1 [9.1] | 1 [12.5] |
P-values2 | 0.544 | 1.000 | 1.000 | |
Lung fibrosis (0.001) | 2 [10.0] | 12 [38.7] | 7 [35.0] | 5 [8.2] |
P-values2 | 0.029 | 0.127 | 1.000 | |
Restrict. pattern PFTs (0.103) | 2 [22.2] | 8 [30.8] | 6 [42.9] | 0 [0.0] |
P-values2 | 1.000 | 0.400 | 0.211 | |
Serositis (0.080) | 3 [15.0] | 6 [19.4] | 3 [15.0] | 2 [3.3] |
P-values2 | 1.000 | 0.019 | 0.094 | |
Renal involvement (0.760) | 0 [0.0] | 0 [0.0] | 0 [0.0] | 1 [1.6] |
P-values2 | - | - | 1.000 | |
Carpal tunnel (0.853) | 2 [10.0] | 3 [9.7] | 3 [15.0] | 5 [4.9] |
P-values2 | 1.000 | 1.000 | 1.000 | |
Per. Neuropathy (0.743) | 1 [5.0] | 2 [6.5] | 0 [0.0] | 3 [86.9] |
P-values2 | 1.000 | 1.000 | 1.000 | |
Leucopenia (0,088) | 2 [10.0] | 2 [6.5] | 2 [10.0] | 15 [24.6] |
P-values2 | 0.640 | 1.000 | 0.216 | |
Hypergammaglobulinaemia (0.0001) | 5 [25.0] | 6 [19.4] | 1 [5.0] | 31 [50.8] |
P-values2 | 0.732 | 0.182 | 0.068 | |
Cryoglobulinaemia (0.609) | 0 [0.0] | 2 [6.5] | 1 [5.0] | 5 [4.9] |
P-values2 | 0.514 | 1.000 | 0.326 | |
RF (0.015) | 5 [25.0] | 6 [19.4] | 4 [20.0] | 29 [47.5] |
P-values2 | 0.732 | 1.000 | 0.117 | |
Low C3,C4 (0.289) | 0 [0.0] | 5 [20.0] | 3 [23.1] | 10 [19.6] |
P-values2 | 0.137 | 0.087 | 0.101 | |
Proteinuria (0.760) | 0 [0.0] | 0 [0.0] | 0 [0.0] | 1 [1.6] |
P-values2 | - | - | 1.000 |
1 Overall P-value from the Chi Square test of independence (significance < 0.05).
2 P-values from the Fisher's exact test comparing the first group with each of the other three groups MSGB: minor salivary gland biopsy, BUT, Tear film break up time, SGE, salivary gland enlargement, GER, gastroesophageal reflux, PAH, pulmonary arterial hypertension, HRCT, high resolution computed tomography, PFT, pulmonary function tests, RF, rheumatoid factor